SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma files ANDA for generic Tykerb

23 Jun 2011 Evaluate

Natco Pharma has filed an Abbreviated New Drug Application (ANDA) for generic version of Lapatimb Ditosylate tablets in 250mg strength. The company is first to file applicant for this product, possibly leading to 180 days marketing exclusivity.

The innovator product (Tykerb tablets by Glaxo), used for the treatment of breast cancer, clocked revenues of $114 million in the USA last year. Natco has partnered with Lupin for marketing of the said product.

Following this, Natco has five IV challenges on hand, with four first to file opportunities.

Natco Pharma was promoted by V C Nannapaneni in the year 1981 as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

1118.95 31.25 (2.87%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×